GlassScriptPhysician profile
Claude Luvis
NPI 1396781548
$818.33
in general payments reported to CMS, 2019-2025
13 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $430 · 2020: $107 · 2021: $92.55 · 2022: $132 · 2023: $56.67.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $56.67.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $56.67 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $318.19 | 2019-2023 | Xarelto |
| Abbvie INC. | $122.76 | 2021-2022 | |
| Astellas Pharma US INC | $58.75 | 2019-2021 | |
| Lilly USA, LLC | $55.35 | 2019-2023 | Mounjaro |
| Astrazeneca Pharmaceuticals LP | $54.82 | 2019-2020 | |
| Sanofi-Aventis U.S. LLC | $42.19 | 2019-2020 | |
| Merck Sharp & Dohme LLC | $40.63 | 2019 | |
| Amgen INC. | $33.82 | 2019-2020 | |
| Novo Nordisk INC | $28.54 | 2021 | |
| Allergan, INC. | $26.66 | 2019 | |
| Daiichi Sankyo INC. | $12.90 | 2019 | |
| Glaxosmithkline, LLC. | $12.22 | 2019 | |
| Scilex Pharmaceuticals INC. | $11.50 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Claude Luvis listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.